{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:32:05Z","timestamp":1780417925995,"version":"3.54.1"},"reference-count":92,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T00:00:00Z","timestamp":1559174400000},"content-version":"vor","delay-in-days":1124,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.5604\/16652681.1198800","type":"journal-article","created":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T08:04:31Z","timestamp":1459843471000},"page":"314-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Management of gastroesophageal varices in cirrhotic patients: current status and future directions"],"prefix":"10.1016","volume":"15","author":[{"given":"Nobuyuki","family":"Toshikuni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Takuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikihiro","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.5604\/16652681.1198800_bib0005","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4254\/wjh.v2.i6.208","article-title":"Physiopa-thology of splanchnic vasodilation in portal hypertension.","volume":"2","author":"Martell","year":"2010","journal-title":"World J Hepatol"},{"key":"10.5604\/16652681.1198800_bib0010","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1053\/j.gastro.2008.03.007","article-title":"Portal hypertension and its complications.","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.5604\/16652681.1198800_bib0015","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4254\/wjh.v7.i4.688","article-title":"Cirrhosis and portal hypertension: The importance of risk stratification, the role of hepatic venous pressure gradient measurement.","volume":"7","author":"La Mura","year":"2015","journal-title":"World J Hepatol"},{"key":"10.5604\/16652681.1198800_bib0020","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/hep.1840050313","article-title":"Portal pressure, presence of gastro-esophageal varices and variceal bleeding.","volume":"5","author":"Garcia-Tsao","year":"1985","journal-title":"Hepatology"},{"issue":"Suppl. 3","key":"10.5604\/16652681.1198800_bib0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2036.2004.02109.x","article-title":"Review article: the relevance of portal pressure and other risk factors in acute gastro-oesophageal variceal bleeding","volume":"20","author":"Dell\u2019era","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.5604\/16652681.1198800_bib0030","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0016-5085(99)70455-5","article-title":"Prognostic value of early measurements of portal pressure in acute variceal bleeding.","volume":"117","author":"Moitinho","year":"1999","journal-title":"Gastroenterology"},{"key":"10.5604\/16652681.1198800_bib0035","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/hep.20386","article-title":"Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding.","volume":"40","author":"Monescillo","year":"2004","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198800_bib0040","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.gie.2006.08.023","article-title":"Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database.","volume":"65","author":"Kovalak","year":"2007","journal-title":"Gastrointest En-dosc"},{"key":"10.5604\/16652681.1198800_bib0045","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198810133191505","article-title":"Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study.","volume":"319","author":"North Italian Endoscopic Club for the","year":"1988","journal-title":"N Engl J Med"},{"key":"10.5604\/16652681.1198800_bib0050","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.cgh.2013.07.015","article-title":"Management of gastric varices.","volume":"12","author":"Garcia-Pagan","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.5604\/16652681.1198800_bib0055","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1053\/gast.2002.33419","article-title":"Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes.","volume":"122","author":"Jensen","year":"2002","journal-title":"Gastroenterology"},{"key":"10.5604\/16652681.1198800_bib0060","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0140-6736(03)12778-X","article-title":"Prevention of variceal rebleeding.","volume":"361","author":"Bosch","year":"2003","journal-title":"Lancet"},{"key":"10.5604\/16652681.1198800_bib0065","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/ajg.2009.31","article-title":"Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.","volume":"104","author":"Bruno","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.5604\/16652681.1198800_bib0070","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-2007-1007133","article-title":"Pharmacological treatment of portal hypertension: an evidence-based approach.","volume":"19","author":"D\u2019Amico","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.5604\/16652681.1198800_bib0075","doi-asserted-by":"crossref","first-page":"16996","DOI":"10.3748\/wjg.v20.i45.16996","article-title":"Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.","volume":"20","author":"Siramolpiwat","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.5604\/16652681.1198800_bib0080","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.surg.2014.12.003","article-title":"Randomized trials of endoscopic therapy and transjugular intrahepatic portosystemic shunt versus portacaval shunt for emergency and elective treatment of bleeding gastric varices in cirrhosis.","volume":"157","author":"Orloff","year":"2015","journal-title":"Surgery"},{"key":"10.5604\/16652681.1198800_bib0085","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2036.2005.02346.x","article-title":"Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophagealvariceal bleeding.","volume":"21","author":"Khuroo","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.5604\/16652681.1198800_bib0090","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1365-2036.2012.05074.x","article-title":"Meta-analysis: banding ligation and medical interventions for the prevention of rebleeding from oesophageal varices.","volume":"35","author":"Thiele","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.5604\/16652681.1198800_bib0095","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/eci.12115","article-title":"Secondary prophylaxis of variceal bleeding for cir-rhotic patients: a multiple-treatments meta-analysis.","volume":"43","author":"Shi","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"10.5604\/16652681.1198800_bib0100","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jhep.2010.09.031","article-title":"Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: a randomized controlled trial.","volume":"54","author":"Mishra","year":"2011","journal-title":"J Hepatol"},{"key":"10.5604\/16652681.1198800_bib0105","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/gut.2009.192039","article-title":"Endo-scopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial.","volume":"59","author":"Mishra","year":"2010","journal-title":"Gut"},{"key":"10.5604\/16652681.1198800_bib0110","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s10620-014-3485-8","article-title":"Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for Treatment of Gastric Varices: Review and Meta-Analysis.","volume":"60","author":"Park","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.5604\/16652681.1198800_bib0115","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.21907","article-title":"Prevention and management of gas-troesophagealvarices and variceal hemorrhage in cirrhosis.","volume":"46","author":"Garcia-Tsao","year":"2007","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198800_bib0120","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension.","volume":"63","author":"de Franchis","year":"2015","journal-title":"J Hepatol"},{"key":"10.5604\/16652681.1198800_bib0125","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/hep.1840160607","article-title":"Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients.","volume":"16","author":"Sarin","year":"1992","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198800_bib0130","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1665-2681(19)32023-X","article-title":"Beta blockers in portal hypertension. Are they really a good option?","volume":"5","author":"Lopez-Mendez","year":"2006","journal-title":"Ann Hepatol"},{"key":"10.5604\/16652681.1198800_bib0135","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.510300124","article-title":"Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.","volume":"30","author":"Banares","year":"1999","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198800_bib0140","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1136\/gutjnl-2012-304038","article-title":"Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynam-ic non-response to propranolol.","volume":"62","author":"Reiberger","year":"2013","journal-title":"Gut"},{"key":"10.5604\/16652681.1198800_bib0145","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ajg.2011.456","article-title":"Development of ascites in compensated cirrhosis with severe portal hypertension treated with beta-blockers.","volume":"107","author":"Hernandez-Gea","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.5604\/16652681.1198800_bib0150","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jhep.2013.09.016","article-title":"The changing role of beta-blocker therapy in patients with cirrhosis.","volume":"60","author":"Ge","year":"2014","journal-title":"J Hepatol"},{"key":"10.5604\/16652681.1198800_bib0155","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1665-2681(19)30934-2","article-title":"Meta-analysis: beta-blockers versus banding ligation for primary prophylaxis of esopha-geal variceal bleeding.","volume":"11","author":"Funakoshi","year":"2012","journal-title":"Ann Hepatol"},{"key":"10.5604\/16652681.1198800_bib0160","first-page":"CD004544","article-title":"Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults.","volume":"8","author":"Gluud","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.5604\/16652681.1198800_bib0165","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1478-3231.2010.02351.x","article-title":"Oesophageal varices in cirrhotic patients: from variceal screening to primary prophylaxis of the first oesophageal variceal bleeding.","volume":"31","author":"Zhang","year":"2011","journal-title":"Liver Int"},{"key":"10.5604\/16652681.1198800_bib0170","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-230X-3-22","article-title":"Endoscopic sclerotherapy compared with no specific treatment for the primary prevention of bleeding from esophageal varices. A randomized controlled multicentre trial [ISRCTN03215899].","volume":"3","author":"van Buuren","year":"2003","journal-title":"BMC Gastroenterol"},{"key":"10.5604\/16652681.1198800_bib0175","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-0031-1284461","article-title":"Transjugular Intrahepatic Portosystemic Shunt (TIPS) versus Balloon-occluded Retrograde Trans-venous Obliteration (BRTO) for the Management of Gastric Varices.","volume":"28","author":"Saad","year":"2011","journal-title":"Semin Intervent Radiol"},{"key":"10.5604\/16652681.1198800_bib0180","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1053\/j.gastro.2004.01.058","article-title":"A pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices.","volume":"126","author":"Ryan","year":"2004","journal-title":"Gastroenterology"},{"key":"10.5604\/16652681.1198800_bib0185","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1055\/s-2002-35312","article-title":"Cyanoacrylate glue in gastric variceal bleeding.","volume":"34","author":"Seewald","year":"2002","journal-title":"Endoscopy"},{"key":"10.5604\/16652681.1198800_bib0190","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.3748\/wjg.v17.i11.1494","article-title":"Long-term result of endoscopic Histoacryl (N-butyl-2-cyanoacrylate) injection for treatment of gastric varices.","volume":"17","author":"Kang","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.5604\/16652681.1198800_bib0195","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/MEG.0b013e3283415986","article-title":"Endoscopic treatment of es-ophageal varices in advanced liver disease patients: band li-gation versus cyanoacrylate injection.","volume":"23","author":"Santos","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.5604\/16652681.1198800_bib0200","first-page":"438","article-title":"A randomized-controlled trial of endoscopic treatment of acute esophageal variceal hemorrhage: N-butyl-2-cyanoacrylate injection vs. variceal ligation.","volume":"58","author":"Ljubicic","year":"2011","journal-title":"Hepatogas-troenterology"},{"key":"10.5604\/16652681.1198800_bib0205","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.gie.2009.03.014","article-title":"Massive hemorrhage from a pulmonary vein-esophageal fistula: a late complication of Histoacryl glue injection.","volume":"70","author":"Barclay","year":"2009","journal-title":"Gastrointest Endosc"},{"key":"10.5604\/16652681.1198800_bib0210","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1440-1746.1996.tb00010.x","article-title":"Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration.","volume":"11","author":"Kanagawa","year":"1996","journal-title":"J Gastroenterol Hepatol"},{"key":"10.5604\/16652681.1198800_bib0215","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0168-8278(01)00185-4","article-title":"Salvage transjugular intrahepatic porto-systemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis.","volume":"35","author":"Azoulay","year":"2001","journal-title":"J Hepatol"},{"key":"10.5604\/16652681.1198800_bib0220","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1007\/s11605-010-1279-7","article-title":"Emergency portacaval shunt versus rescue portacaval shunt in a randomized controlled trial of emergency treatment of acutely bleeding esophageal varices in cirrhosis\u2014part 3.","volume":"14","author":"Orloff","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"10.5604\/16652681.1198800_bib0225","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/jamasurg.2013.4045","article-title":"Fifty-three years\u2019 experience with randomized clinical trials of emergency portacaval shunt for bleeding es-ophageal varices in Cirrhosis: 1958-2011.","volume":"149","author":"Orloff","year":"2014","journal-title":"JAMA Surg"},{"key":"10.5604\/16652681.1198800_bib0230","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0016-5085(98)00640-4","article-title":"\u201cSalvage\u201d transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding.","volume":"114","author":"Chau","year":"1998","journal-title":"Gastroenterology"},{"key":"10.5604\/16652681.1198800_bib0235","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/MCG.0b013e31811edcd1","article-title":"The therapeutic effect of cyanoacrylate on gastric variceal bleeding and factors related to clinical outcome.","volume":"42","author":"Paik","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.5604\/16652681.1198800_bib0240","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/hep.21145","article-title":"A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation.","volume":"43","author":"Tan","year":"2006","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198800_bib0245","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1056\/NEJMoa0910102","article-title":"Early use of TIPS in patients with cirrhosis and variceal bleeding.","volume":"362","author":"Garcia-Pagan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.5604\/16652681.1198800_bib0250","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2012.08.020","article-title":"Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study.","volume":"58","author":"Garcia-Pagan","year":"2013","journal-title":"J Hepatol"},{"key":"10.5604\/16652681.1198800_bib0255","doi-asserted-by":"crossref","unstructured":"Sauerbruch T, Mengel M, Dollinger M, Zipprich A, Rossle M, Panther E, Wiest R, et al. Prevention of Rebleeding from Es-ophageal Varices in Patients with Cirrhosis Receiving Small-diameter Stents vs. Hemodynamically Controlled Medical Therapy. Gastroenterology 2015.","DOI":"10.1053\/j.gastro.2015.05.011"},{"key":"10.5604\/16652681.1198800_bib0260","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1053\/j.gastro.2003.11.016","article-title":"Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study.","volume":"126","author":"Bureau","year":"2004","journal-title":"Gastroenterology"},{"key":"10.5604\/16652681.1198800_bib0265","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/liv.12452","article-title":"Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review.","volume":"34","author":"Puente","year":"2014","journal-title":"Liver Int"},{"key":"10.5604\/16652681.1198800_bib0270","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/hep.1840110212","article-title":"Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.","volume":"11","author":"Garcia-Pagan","year":"1990","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198800_bib0275","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jhep.2011.12.021","article-title":"Efficacy of non-selective beta-blockers as adjunct to endoscopic prophylactic treatment for gastric variceal bleeding: a randomized controlled trial.","volume":"56","author":"Hung","year":"2012","journal-title":"J Hepatol"},{"key":"10.5604\/16652681.1198800_bib0280","first-page":"679","article-title":"A prospective, randomized controlled trial of transjugu-lar intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding.","volume":"39","author":"Lo","year":"2007","journal-title":"En-doscopy"},{"key":"10.5604\/16652681.1198800_bib0285","first-page":"CD010180","article-title":"En-doscopic injection of cyanoacrylate glue versus other endo-scopic procedures for acute bleeding gastric varices in people with portal hypertension.","volume":"5","author":"Rios Castellanos","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.5604\/16652681.1198800_bib0290","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.","volume":"133","author":"Ripoll","year":"2007","journal-title":"Gastroenterology"},{"key":"10.5604\/16652681.1198800_bib0295","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1053\/gast.1996.v111.pm8780575","article-title":"Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study.","volume":"111","author":"Vorobioff","year":"1996","journal-title":"Gastroenterology"},{"key":"10.5604\/16652681.1198800_bib0300","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2036.2008.03798.x","article-title":"Review article: the therapeutic and prognostic benefit of portal pressure reduction in cirrhosis.","volume":"28","author":"Triantos","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.5604\/16652681.1198800_bib0305","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/hep.1840360611","article-title":"\u201cA La Carte\u201d treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding.","volume":"36","author":"Bureau","year":"2002","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198800_bib0310","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-2036.2009.04015.x","article-title":"Early identification of haemodynamic response to pharmacotherapy is essential for primary prophylaxis of variceal bleeding in patients with \u2018high-risk\u2019varices.","volume":"30","author":"Sharma","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.5604\/16652681.1198800_bib0315","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1053\/j.gastro.2012.05.035","article-title":"Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis.","volume":"143","author":"Colecchia","year":"2012","journal-title":"Gastroenterology"},{"key":"10.5604\/16652681.1198800_bib0320","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2012.10.001","article-title":"Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis.","volume":"144","author":"Berzigotti","year":"2013","journal-title":"Gastroenterology"},{"key":"10.5604\/16652681.1198800_bib0325","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1053\/j.gastro.2012.09.049","article-title":"Measurement of spleen stiffness by acoustic radiation force impulse imaging identifies cirrhotic patients with esophageal varices.","volume":"144","author":"Takuma","year":"2013","journal-title":"Gastroen-terology"},{"key":"10.5604\/16652681.1198800_bib0330","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/ajg.2013.119","article-title":"Spleen stiffness in patients with cirrhosis in predicting esophageal varices.","volume":"108","author":"Sharma","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.5604\/16652681.1198800_bib0335","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jhep.2014.12.007","article-title":"Real-time shear-wave elastography: applicability, reliability and accuracy for clinically significant portal hypertension.","volume":"62","author":"Procopet","year":"2015","journal-title":"J Hepatol"},{"key":"10.5604\/16652681.1198800_bib0340","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1148\/radiol.14140008","article-title":"Shear-wave elastography: a noninvasive tool for monitoring changing hepatic venous pressure gradients in patients with cirrhosis.","volume":"273","author":"Choi","year":"2014","journal-title":"Radiology"},{"key":"10.5604\/16652681.1198800_bib0345","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/jmri.24186","article-title":"Usefulness of MR elastog-raphy for predicting esophageal varices in cirrhotic patients.","volume":"39","author":"Sun","year":"2014","journal-title":"J Magn Reson Imaging"},{"key":"10.5604\/16652681.1198800_bib0350","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1148\/radiol.14130916","article-title":"Prediction of esophageal varices in patients with cirrhosis: usefulness of three-dimensional MR elastography with echo-planar imaging technique.","volume":"272","author":"Shin","year":"2014","journal-title":"Radiology"},{"key":"10.5604\/16652681.1198800_bib0355","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2036.2007.03378.x","article-title":"Relationship between the Fibrotest and portal hypertension in patients with liver disease.","volume":"26","author":"Thabut","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.5604\/16652681.1198800_bib0360","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jhep.2013.11.016","article-title":"Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest) and transient elastography (FibroScan(R)).","volume":"60","author":"Poynard","year":"2014","journal-title":"J Hepatol"},{"key":"10.5604\/16652681.1198800_bib0365","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/hep.27249","article-title":"Prevention of portal hypertension: from variceal development to clinical decompensation.","volume":"61","author":"Vorobioff","year":"2015","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198800_bib0370","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","article-title":"Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.","volume":"353","author":"Groszmann","year":"2005","journal-title":"N Engl J Med"},{"key":"10.5604\/16652681.1198800_bib0375","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep.23785","article-title":"Long-term entecavir therapy results in the reversal of fibrosis\/cirrhosis and continued histological improvement in patients with chronic hepatitis B.","volume":"52","author":"Chang","year":"2010","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198800_bib0380","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.","volume":"381","author":"Marcellin","year":"2013","journal-title":"Lancet"},{"key":"10.5604\/16652681.1198800_bib0385","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1053\/gast.2002.33023","article-title":"Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.","volume":"122","author":"Poynard","year":"2002","journal-title":"Gastroenterology"},{"key":"10.5604\/16652681.1198800_bib0390","doi-asserted-by":"crossref","first-page":"399","DOI":"10.7326\/0003-4819-149-6-200809160-00006","article-title":"Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatitis C.","volume":"149","author":"Mallet","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.5604\/16652681.1198800_bib0395","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.25606","article-title":"A morphometric and immunohis-tochemical study to assess the benefit of a sustained viro-logical response in hepatitis C virus patients with cirrhosis.","volume":"56","author":"D\u2019Ambrosio","year":"2012","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198800_bib0400","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.cgh.2007.02.022","article-title":"Effect of sustained viral response on hepatic venous pressure gradient in hepatitis C-related cirrhosis.","volume":"5","author":"Roberts","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.5604\/16652681.1198800_bib0405","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1002\/hep.23528","article-title":"Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study.","volume":"51","author":"Bruno","year":"2010","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198800_bib0410","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1473-3099(15)70050-2","article-title":"Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous pro-tease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS).","volume":"15","author":"Bourliere","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.5604\/16652681.1198800_bib0415","unstructured":"Charlton M, Everson GT, FlammSL, Kumar P, Landis C, Brown RS, Jr., Fried MW, et al. Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients with Advanced Liver Disease. Gastroenterology 2015."},{"key":"10.5604\/16652681.1198800_bib0420","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa1402869","article-title":"ABT-450\/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis.","volume":"370","author":"Poordad","year":"2014","journal-title":"N Engl J Med"},{"key":"10.5604\/16652681.1198800_bib0425","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jhep.2013.04.035","article-title":"Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) -NCT01514890.","volume":"59","author":"Hezode","year":"2013","journal-title":"J Hepatol"},{"key":"10.5604\/16652681.1198800_bib0430","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.gastro.2014.03.051","article-title":"Effectiveness of telaprevir or bo-ceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.","volume":"147","author":"Hezode","year":"2014","journal-title":"Gastroenterology"},{"key":"10.5604\/16652681.1198800_bib0435","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jhep.2014.06.027","article-title":"Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest(R)) and elastography (FibroScan(R)).","volume":"61","author":"Poynard","year":"2014","journal-title":"J Hepatol"},{"key":"10.5604\/16652681.1198800_bib0440","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2013.05.015","article-title":"Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C.","volume":"59","author":"Poynard","year":"2013","journal-title":"J Hepatol"},{"key":"10.5604\/16652681.1198800_bib0445","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00535-012-0679-8","article-title":"Risk factors for the exacerbation of esophageal varices or portosystemic encephalopathy after sustained virological response with IFN therapy for HCV-related compensated cirrhosis.","volume":"48","author":"Nagaoki","year":"2013","journal-title":"J Gastroenterol"},{"key":"10.5604\/16652681.1198800_bib0450","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI66028","article-title":"Evolving therapies for liver fibrosis.","volume":"123","author":"Schuppan","year":"2013","journal-title":"J Clin Invest"},{"key":"10.5604\/16652681.1198800_bib0455","unstructured":"N JT, Dranoff JA, Schuppan D, Friedman SL. Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014. Hepatology 2015."},{"key":"10.5604\/16652681.1198800_bib0460","doi-asserted-by":"crossref","unstructured":"Jaroszewicz J, Flisiak-Jackiewicz M, Lebensztejn D, Flisiak R. Current drugs in early development for treating hepatitis C virus-related hepatic fibrosis. Expert Opin Investig Drugs 2015: 1-11.","DOI":"10.1517\/13543784.2015.1057568"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119306507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119306507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/publisherspanel.com\/icid\/pdf\/1198800","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:34:29Z","timestamp":1761647669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268119306507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":92,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S1665268119306507"],"URL":"https:\/\/doi.org\/10.5604\/16652681.1198800","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of gastroesophageal varices in cirrhotic patients: current status and future directions","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.5604\/16652681.1198800","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.","name":"copyright","label":"Copyright"}]}}